Cargando…
Roxithromycin monotherapy inducing a partial response in a patient with myeloma: a case report
BACKGROUND: Clarithromycin is an efficacious treatment for myeloma in combination with other anti-myeloma therapy but not as monotherapy. To date, all studies have focused on a clarithromycin-specific effect rather than a class effect (macrolide) and there is no information on the activity of roxith...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944102/ https://www.ncbi.nlm.nih.gov/pubmed/29743095 http://dx.doi.org/10.1186/s13256-018-1636-9 |